Drug research and allied services has gained a stronghold foothold in India. The introduction of Patents Act 1970 followed by WTO- TRIPS (2005) witnessed upsurge activities in areas of drug research in India. It's worth to mention that Indian pharma companies were active in research since late 1990.

India has been successful in contributing quality medicines at affordable prices. Also India is now considered as genuine intellectual contributor and partner in drug research arena.

Major collaborations and research service agreements took place meanwhile where both Indian Pharma companies and MNC were seen leveraging each other capabilities in area of drug research.

The research report "Drug Research Scenario in India" reveals how and what Indian companies are doing in the area of drug research, and details out which companies are most active in the area. It mentions historic perspective, current scenario and recent trends shaping up place in Drug research and comprises of 45 slides with information on drug research activities and allied services being carried out in India.

Below is a view of its Table of content:

  • Overview: Historical perspective of Indian Pharma market
  • Current status
    • Top 10 Indian Pharma companies by Sales and their R&D Expenses
    • Deals : Partnering of MNCs with Indian companies- Collaborative research, R&D service agreement
    • Paradigm Shift- "Hybrid Model"
    • India as a destination for conducting clinical research outsourcing and conducting global trials
    • MNC CRO in India
    • Indian companies' move up the value curves 
  • Trends in Drug Research
    • Top 5 Therapy areas for Drug Research
    • Key therapy area for NCE of 10 Indian companies
    • Therapeutic segment sales as of March 2011 
  • India's IP regime & Government Initiatives
  • Benefits of Collaborations
  • Conclusion

More about the report, including a downloadable summary pdf, can be accessed using the link: